Patents
Patents for C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516)
07/2000
07/19/2000EP1019060A1 Androgen synthesis inhibitors
07/19/2000EP0641355B1 Use of sulphamate derivatives as steroid sulphatase inhibitors
07/18/2000US6090957 Process for preparing neuromuscular blocking agents and intermediates useful therefor
07/06/2000WO2000039148A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases
07/05/2000EP0554436B1 Gaba receptor modulators
07/05/2000CN1054133C 17-spiromethylene steroids
06/2000
06/29/2000DE19860719A1 Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen New testosterone derivatives and their use for long-term therapy of androgen-dependent diseases
06/27/2000US6080735 Estra-1,3,5(10)-trien derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
06/27/2000US6080591 Useful in biological assays for determination of vitamin b12, folate, cortisol, estradiol, and thromboxane b2
06/06/2000US6072068 Treating glucocorticoid-dependent diseases or symptoms
06/06/2000US6071890 Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
05/2000
05/09/2000US6060598 Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding
04/2000
04/25/2000US6054446 17-substituted-17-desoxy-1,3,5-estratrienes.
04/25/2000CA2001936C Methods and compositions for controlling ocular hypertension with angiostatic steroids
04/13/2000WO2000020437A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism
04/13/2000DE19845403A1 Mit Gallensäuren verknüpfte Porpanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung With bile acids linked Porpanolaminderivate, processes for their preparation, pharmaceutical compositions containing them and their use
04/13/2000CA2346085A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism
04/12/2000CN1051316C Cortinoid derivative, its producing process and medicine containing the same
04/04/2000US6046182 Steroid carbamates as potentiating agents
03/2000
03/28/2000US6043235 11β-aryl-17, 17-spirothiolane-substituted steroids
03/22/2000CN1248262A 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
03/08/2000CN1246865A Antigestagenic steroids with fluorinated 17 'alpha'-alkyl chair
03/02/2000WO2000011019A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agent
03/02/2000WO2000011018A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents
03/01/2000EP0982298A1 Novel functionalized hydrophilic acridinium esters
03/01/2000EP0982032A2 Use of a ring system compound comprising a sulphamic acid ester group for the manufacture of medicaments for the control of oestrogen production
02/2000
02/22/2000US6028207 A tetracycline type antibiotic covalent bonded with a steroid type hormone estrogen has an osteogenesis function in addition to a bone resorption inhibition, can concentrate on the bone tissues
02/10/2000WO2000006585A1 Medicine nitrate salts
02/10/2000CA2338912A1 Medicine nitrate salts
02/01/2000US6020328 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
01/2000
01/26/2000EP0973792A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
01/19/2000CN1048499C Process for preparing appropriate salt of 11 beta-aryl-4-estrene pharmaceutical composition
01/18/2000US6015806 Topical use in the treatment of androgen-dependent diseases associated with the skin.
01/18/2000US6015805 Potent antiprogestational activity and are useful in the treatment of fibroids, endometriosis, cervical ripening prior to delivery, hormone replacement therapy and in the control of fertility.
01/12/2000EP0970103A1 Antigestagenic steroids with a fluorinated 17alpha-alkyl chain
12/1999
12/29/1999WO1999067274A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
12/29/1999CA2336167A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
12/23/1999WO1999033859A3 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
12/22/1999EP0515386B1 Glycoalkaloids
12/21/1999US6005087 Nuclease resistant oligonucleotides which are useful as therapeutics, diagnostics, and research reagents for various viral diseases
12/09/1999WO1999062929A1 17β-NITRO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
12/09/1999WO1999062928A1 17β-AMINO AND HYDROXYLAMINO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
11/1999
11/30/1999US5994335 17-azolyl steroids useful as androgen synthesis inhibitors
11/30/1999US5994334 Androgen synthesis inhibitors
11/24/1999EP0633893B1 17-substituted steroids useful in cancer treatment
11/24/1999CN1046736C 'Delta' 16 unsaturated and (1) heterocyclic steroids useful s steroid (1)-20 lyase inhibitors
11/18/1999WO1999058549A1 Meiosis regulating compounds
11/18/1999CA2331962A1 Meiosis regulating compounds
11/17/1999CN1235594A Methods and compositions for lipidization of hydrophilic molecules
11/16/1999US5986115 7α-(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents
11/10/1999EP0954339A2 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
11/10/1999EP0954338A2 Cationic amphiphile/dna complexes
11/02/1999US5977094 Methods and compositions using Δ16 unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitors
10/1999
10/13/1999CN1231670A 7 'alpha'-('xi'-aminoalkyl) estratrienes, process for preparing the same, pharmaceutical preparations containing the same, and their use for preparing medicaments
10/12/1999US5965548 For treatment of prostatic cancer, breast cancer
10/06/1999EP0946586A1 Aminosterol ester compounds
10/05/1999US5962444 Hormone inhibitor; hormone replacement therapy
09/1999
09/28/1999US5958901 Delivery of anionic macromolecules into cells.
09/28/1999US5958770 Glycoalkaloids
09/23/1999WO1999033859A9 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
09/21/1999US5955455 Therapeutic methods and delivery systems utilizing sex steroid precursors
09/14/1999US5952183 Synthesis of estrogen-purine base and estrogen-mercapturate adducts and development of fluorescent probes and monoclonal antibodies to assay those adducts
09/10/1999WO1999045024A1 Cholenic acid amides and pharmaceutical compositions thereof
09/10/1999WO1999045023A1 S-SUBSTITUTED 11β-BENZALDOXIME-ESTRA-4,9-DIENE-CARBONIC ACID THIOLESTERS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
09/10/1999WO1999045022A1 20-KETO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
09/10/1999WO1999044616A1 Steroid derived antibiotics
09/09/1999DE19809845A1 S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen For their preparation and compositions containing these compounds S-11beta-substituted benzaldoxime-estra-4,9-dien-kohlensäurethiolester, procedures pharmaceutical preparations
09/07/1999US5948767 Transport of active material into cells; drug delivery
09/07/1999US5948434 Administering dehydroepiandrosterone or dehydroepiandrosterone sulphate via transdermal patch
08/1999
08/31/1999US5945404 21-Substituted steroid compound
08/17/1999US5939545 Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
08/17/1999US5939401 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
08/12/1999DE19806357A1 New 11 beta-halo-7 alpha-substituted estratrienes useful for treating e.g. estrogen-dependent disease such as breast cancer
08/11/1999EP0649431B1 17-amino substituted 4-azasteroid 5-alpha-reductase inhibitors
08/04/1999CN1044476C Chelate and preparation thereof
07/1999
07/21/1999EP0565553B1 6,7-MODIFIED 11$g(b)-ARYL-4-ESTRENES
07/20/1999US5925630 Neuroactive steroids of the androstane and pregnane series
07/14/1999EP0928609A2 Use of sulphamate derivatives as steroid sulphatase inhibitors
07/13/1999US5922703 Useful for treating congestive heart failure
07/13/1999US5922700 Kit for drug delivery of steroids
07/08/1999WO1999033859A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
07/08/1999WO1999033855A1 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS
07/08/1999CA2316444A1 11.beta.-halogen-7.alpha.-substituted estratrienes, process for the production of pharmaceutical preparations that contain these 11.beta.-halogen-7.alpha.-substituted estratrienesas well as their use for the production of pharmaceutical agents
07/06/1999US5919922 Fluorescent dyes free of aggregation and serum binding
07/01/1999DE19758390A1 New 11beta-halo-7alpha-substituted-estratriene derivatives are useful for treatment e.g. various cancers, anovulatolial infertility, male hair loss, osteoporosis, and contraceptives
06/1999
06/22/1999US5914324 6-Hydroxy and 6-oxo-androstane derivatives active on the cardiovascular system and pharmaceutical compositions containing same
06/15/1999US5912239 Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules
06/09/1999EP0921130A2 Steroid sulphatase inhibitors
06/09/1999EP0920441A1 7alpha-(epsilon-aminoalkyl)-estratrienes, process for preparing the same, pharmaceutical preparations containing said 7alpha-(epsilon-aminoalkyl)-estratrienes and their use for preparing medicament
06/08/1999US5910487 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
05/1999
05/27/1999WO1999025725A1 NOVEL 19-NOR STEROIDS SUBSTITUTED IN POSITION 11β, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
05/27/1999CA2309242A1 Novel 19-nor steroids substituted in position 11.beta., preparation method and intermediates, application as medicines and pharmaceutical compositions containing them
05/20/1999WO1998013007A8 Methods and compositions for lipidization of hydrophilic molecules
05/19/1999EP0916676A1 Synthesis of 6 alpha-functionalized estriol haptens and protein conjugate thereof
05/19/1999EP0916658A1 Assays utilizing improved chemiluminescent esters, thioesters and amides
05/11/1999US5902888 Synthesis of 6α-functionalized estriol haptens and protein conjugates thereof
05/06/1999EP0912179A1 Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors
05/06/1999EP0589034B1 Method for making 3-alpha-hydroxy,3-beta-substituted-pregnanes
04/1999
04/29/1999WO1999020646A1 Estra-1,3,5(10)-triene-7alpha-thioethers
04/29/1999CA2308773A1 Estra-1,3,5(10)-triene-7alpha-thioethers
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 26